UiPath: A Solid Quarter the Rally Already Priced In

UiPath reported fiscal second-quarter results on Thursday evening that beat its own guidance on nearly every line. Revenue came in at $410 million, up 13 percent from a year ago, annualized recurring revenue (ARR) reached $1.938 billion, and the company nudged its full-year revenue forecast to roughly $1.79 billion. By the usual read, that is a clean quarter.

The trouble is that the market had already decided how good it was before the numbers landed. UiPath shares had climbed about 40 percent in the month before earnings, traded near their 52-week high, and jumped 9 percent in a single late-August session on a broad software rally tied to Nvidia's results — none of it company-specific. The report is being absorbed by a stock that had already re-rated like an accelerating AI story. Whether it should stay that way depends on one number the company quietly tucked into the press release: net new ARR of $37 million.

The demand engine, not the headline

For a subscription software company, ARR matters more than the revenue line because it reflects the annualized value of contracts signed. Net new ARR is the purest read on whether demand is actually accelerating. UiPath added $37 million in the quarter — better than the $31 million it added in the same quarter a year ago, a roughly 19 percent improvement — but small in absolute terms against a $1.9 billion base and a $9.4 billion market cap.

Notice what the number says alongside the headline. Revenue growth actually slowed to 13 percent from 17 percent in the prior quarter, and ARR grew 12 percent. Net retention was 109 percent, meaning existing customers spend about 9 percent more each year — solid, recession-resistant behavior, but not a breakout. The story that floored the last two years — that AI agents would turn UiPath's robot-automation base into a much faster grower — still reads in the numbers as a low-teens grower with a modestly improving demand engine. There is evidence behind the narrative, just not the volume the multiple assumes.

The fundamentals underneath are genuinely healthy. Non-GAAP operating income was $89 million, operating cash flow was $31 million, and the company holds about $1.4 billion in cash and marketable securities against modest debt. This is not a broken or burning business. It is a profitable, cash-generative, middle-aged software company that fumbled its last growth cycle, reorganized, and is now delivering reliable beats. That is worth something — it is just not the same thing as an accelerating one.

What the valuation now demands

The market is paying roughly 5.6 times trailing sales and close to 20 times forward non-GAAP operating income after holding $1.4 billion in cash — a full multiple for a business growing revenue in the low teens. Management's own full-year guide backs the current trajectory: revenue of $1.789 billion to $1.794 billion and non-GAAP operating income of about $445 million. That rewards continued execution, but it does not reward a miss on acceleration. The stock has run so far ahead of this quarter's proof that the next report carries most of the risk.

That is the difference between this company and this stock. UiPath is a better business than a year ago, when the shares bottomed near $9 and the market doubted the agentic-automation pitch entirely. Since then the stock has roughly doubled and now sits within striking distance of its high. The valuation has reset from "discounted and unloved" to "paying up for a turnaround." The risk/reward has inverted.

The proof point that decides it is net new ARR. If the next couple of quarters show net new ARR climbing from $37 million toward the $50 million range — driven by the new Maestro Case and Maestro Flow products management is unveiling — then the re-rating is earning itself and this becomes a genuine acceleration. If it stalls around $40 million or below, investors are paying an acceleration multiple for a 12 percent grower, and the rally is a head start, not a signal.

For a retail investor with no position, the honest reading is "too early to chase." The quarter is good, the balance sheet is clean, and the CEO's case that AI expands what automation orchestration can capture is plausible. But the price already banked the optimistic version of that story, and the operating data are not yet proving it. The disciplined move is to let the next report supply the evidence — to wait for net new ARR to show up before paying for it.